Page last updated: 2024-08-21

isoxazoles and Male Genitourinary Diseases

isoxazoles has been researched along with Male Genitourinary Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batteiger, BE; Hook, EW; Johnson, SM; Kwak, H; Lawrence, K; Long, J; Marrazzo, J; Mueller, J; Seña, AC; Taylor, SN; Wierzbicki, MR1

Trials

1 trial(s) available for isoxazoles and Male Genitourinary Diseases

ArticleYear
Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
    The New England journal of medicine, 2018, 11-08, Volume: 379, Issue:19

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Barbiturates; Ceftriaxone; Female; Female Urogenital Diseases; Gonorrhea; Humans; Injections, Intramuscular; Intention to Treat Analysis; Isoxazoles; Male; Male Urogenital Diseases; Microbial Sensitivity Tests; Middle Aged; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Pharyngeal Diseases; Rectal Diseases; Sexual Partners; Spiro Compounds; Treatment Outcome; Young Adult

2018